Washburn Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,440
Closed -$268K 59
2020
Q4
$268K Buy
3,440
+264
+8% +$20.2K 0.19% 53
2020
Q3
$251K Sell
3,176
-339
-10% -$26.6K 0.2% 49
2020
Q2
$259K Sell
3,515
-80
-2% -$6.02K 0.24% 44
2020
Q1
$264K Sell
3,595
-2,433
-40% -$191K 0.36% 36
2019
Q4
$523K Buy
+6,028
New +$495K 0.47% 24

Other funds holding MRK

Washburn Capital Management's MRK Position: Q1 2021 in Review

Washburn Capital Management sold out of Merck (MRK) in Q1 2021, closing a stake of 3,440 shares — an estimated $268K sold.

Washburn Capital Management first reported a position in MRK in Q4 2019 and held it in 5 quarters. The position peaked at $523K in Q4 2019. 2,686 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • Washburn Capital Management reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
  • Washburn Capital Management sold 3,440 Merck shares in Q1 2021, an estimated $268K.
  • Washburn Capital Management first reported a position in Merck in Q4 2019 and held it in 5 quarters.
  • Washburn Capital Management's Merck position peaked at $523K in Q4 2019.
  • 2,686 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on Washburn Capital Management's 13F filing for Q1 2021, filed 3 May 2021.